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ABSTRACT 
A male patient with bipolar disorder who developed Stevens Johnson Syndrome following 
treatment with a combination of sodium valproate and lamotrigine is reported. This case report 
emphasises the importance of being cautious when such a combination is used in patients with 
associated medical conditions. 
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Lamotrigine, an anticonvlsant of 
phenyltriazine class was shown to have positive 
effects on mood during its clinical development 
for epilepsy (Smith et al., 1998). Reports of the 
effectiveness of lamotrigine in treating bipolar 
disorder appeared in 1994 (Weisler etal., 1994). 
Since that time there have been reports describing 
moderate to marked broad spectrum efficacy of 
lamotrigine in the treatment of depressed, 
hypomanic, manic and mixed phases of bipolar 
disorder (Calabrese etal., 1999; Erfuthetal., 1998; 
Kotleretal., 1998; Fogelsonetal., 1997; Labbate 
etal., 1997). 
The most commonly observed adverse 
effects associated with the use of lamotrigine are 
dizziness, ataxia, somnolence, headache, 
diplopia, blurred vision, nausea and rash. Rash 
usually occurs in two to eight weeks of treatment 
initiation. (Sussman, 2000). Risk factors for rash 
are age, combining lamotrigine with valproic acid 
and exceeding the recommended rate of dose 
escalation for lamotrigine. Rarely angioedema and 
Stevens- Johnson syndrome have been reported. 
Stevens-Johnson syndrome is an acute, 
inflammatory polmorphic eruption which is a 
reaction to many different stimuli. It is 
characterized by a muco-cutaneous involvement 
in the form of erythematous macules, papules, 
vesicles, bullae and erosions. The diagnostic 
lesions are called "target lesions" which show a 
central discolouration, a zone of pallor with an 
outer ring of erythema. The mucous membrane of 
the eyes, oral cavity and genitalia is involved. 
(Rook, etal, 1998). 
The disease may occur as a primary 
manifestation of systemic infections, malignant 
or chronic disease of internal organs or as a 
reaction to ingested drugs like sulphonamides, 
penicillins, phenytoin, phenylbutazone and 
carbamazepine (Rees & Rees, 1984). The 
following case report describes a bipolar patient 
who developed this condition solely due to 
lamotrigine. 
Case Report: Mr. G. Y, fifty seven years old married 
male was admitted with a fortnight history of 
symptoms suggestive of mania. He had a past 
history of eight manic and four depressive 
episodes over a period of twenty-nine years. He 
was detected to have diabetes mellitus and 
hypertension four and three years back 
respectively. Diabetes and hypertension were 
being controlled with glibenclamide 20 mg before 
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breakfast and enalapril 5 mg daily till nine months 
back, when the antidiabetic was changed to 
metformin 250 mg twice daily. 
Onset of illness was twenty-nine years back 
with a manic episode for which he was 
hospitalised. The episode was treated with 
haloperidol. He later had two manic and one 
depressive episodes. Lithium was initiated eight 
years back during the fifth episode. It had to be 
discontiued after one year as the patient had two 
syncopal attacks. Carbamazepine was introduced 
in a dose of 600 mg a day but the compliance 
was poor as the patient would consume alcohol. 
The patient had to be hospitalised subsequently 
with manic and depressive episodes (with 
psychotic features) once every year. During each 
episode he would switch either from mania to 
depression or vice versa and would respond only 
to electroconvulsive therapy. 
Nine months back he developed papular 
rash over the extensor surfaces and oral lesions. 
Hence carbamazepine was withdrawn and patient 
was switched on to clonazepam 6 mg a day. 
His last admission was four months back 
with a fifteen days history of symptoms suggestive 
of mania. Sodium valproate was introduced 600mg 
a day and was later increased to 1200 mg a day 
but his manic symptoms remained the same even 
after two weeks of therapy. Nifedipine 15 mg a 
day was used as a substitue for enalapril. Dosage 
of nifedipine could not be increased further as 
the blood pressure was stabilized. There was no 
response even after one month of therapy. 
Electroconvulsive therapy was witheld as the 
patient had received seven ECT's two months prior 
to the present admission. Lamotrigine 25 mg a 
day was added and it was increased to 75 mg a 
day by the third week. Patient was discharged in 
the fourth week when the manic symptoms had 
remitted. 
Patient reported to the outpatient 
Department on the fourth day after discharge with 
history of rash, discharge from the eyes, 
dysphagia and haematuria of two days duration. 
On examination he was found to have temperature 
101° F and bilateral inguinal lymphadenopathy. 
There were bilaterally symmetrical lesions in the 
form of erythematous papules, papulovesicles, 
bullae, erosions and target lessions all over the 
body including the palms and soles. There was 
thick purulent discharge from both eyes, erosions 
and ulcers were present in the oral mucous 
membrane and the lips had thick haemorrhagic 
crusting. A few erosions and erythematous 
papules were present on the genitalia. Patient was 
admitted in the Department of Dermatology. 
Treatment given included intravenous ofloxacin 400 
mg, 12 hourly, chlorpheniramine maleate 50 mg 
12 hourly, crystalline insulin according to urine 
sugar chart and symptomatic treatment for oral 
mucous membrane lesions and conjuntivitis. 
Systemic steroids were to be started but his 
condition deteriorated rapidly and he expired on 
the second day of admission. 
The following were the laboratory 
investigation reports: Hb-10gm%; TLC-6000/ 
cumm; N-86%; L-13%; M-1%; platlet count 
80,000/ cumm; RBSL-280 mg%. Urine analysis 
showed albumin ++, sugar ++++, RBCs 8-9/HPF; 
pus cells 45/HPF; blood urea-65mgs%; serum 
creatinine 1 2mg%; urine for ketones was negative; 
serum electrolytes and liver function tests were 
within normal limits; X-ray chest was normal. 
DISCUSSION 
Lamotrigine is being used in the treatment 
of refractory epilepsy since the last six years 
and rare cases of rash related deaths have been 
reported in worldwide postmarketing experience. 
Although a few cases of Stevens Johnson 
syndrome have been reported in the clinical 
studies of patients treated with lamotrigine, there 
are no reported deaths till date. The condition 
was probably caused by lamotrigine. Our patient 
was receiving sodium valproate along with 
lamotrigine which is a known risk factor to develop 
rash. In addition our patient had medical 
conditions like septicaemia, urinary tract 
infection diabetes mellitus and he reported late. 
All this might have contributed to the non 
recovery. 
The occurrence of such a death cautions 
us that a combination of lamotrigine and 
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valproate should be used judiciously in patients 
with mood disorders having associated medical 
conditions. The benefits of such a combination 
are to be weighed against disastrous side effects 
before starting the therapy. 
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